San Diego, CA, United States of America

John M Pawelchak

This inventor holds 2 USPTO granted patents. Top assignees: Gensia Pharmaceuticals, Inc., Gensia, Inc.. Active years: 1992-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John M Pawelchak. Retrieved from https://idiyas.com/inventor/john-m-pawelchak-vxi8kms3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1992-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John M Pawelchak: Innovator in Iontophoretic Drug Delivery

Introduction

John M Pawelchak is a notable inventor based in San Diego, CA. He has made significant contributions to the field of drug delivery systems, particularly through his work on iontophoretic administration methods. With a total of 2 patents, his innovations aim to enhance the effectiveness of drug delivery through the skin.

Latest Patents

Pawelchak's latest patents include groundbreaking methods and systems for improved iontophoretic administration of drugs. One of his patents focuses on the iontophoretic administration of a formulation containing active vasodilators, rubefacients, or counterirritant agents like capsaicin. This method allows for topical administration at the electrode site, enhancing drug absorption. Another patent details an apparatus and method for iontophoretic transdermal delivery of exercise-simulating agents. This invention includes an electrode with a drug reservoir that contains a viscosity-control agent, an antioxidant, a preservative, a chelator, and a buffer, all designed to facilitate effective drug delivery.

Career Highlights

Throughout his career, John M Pawelchak has worked with prominent companies such as Gensia Pharmaceuticals, Inc. and Gensia, Inc. His experience in these organizations has contributed to his expertise in drug delivery technologies and innovation.

Collaborations

Pawelchak has collaborated with various professionals in his field, including Robert S Hillman, enhancing the development of his innovative solutions.

Conclusion

John M Pawelchak's contributions to iontophoretic drug delivery systems demonstrate his commitment to advancing medical technology. His patents reflect a deep understanding of drug administration methods, which could significantly impact patient care in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…